Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
The Independent on MSN
New blood test could show if prostate cancer treatment is failing
New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...
The Government’s plans for prostate cancer screening do not go far enough, experts have warned. James Murray, the new Health ...
Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...
Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...
The Health Secretary has confirmed that thousands more Black men will be invited to participate in a prostate cancer ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in ...
The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...
Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...
Experts are trying to find the best way to screen for prostate cancer, since blood tests alone are not accurate enough for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results